University of Groningen, Faculty of Science and Engineering, Department of Pharmacy, Nijenborgh 4, 9747AG Groningen, the Netherlands.
Netherlands Forensic Institute, Laan van Ypenburg 6, 2497GB The Hague, the Netherlands.
Forensic Sci Int. 2023 Dec;353:111876. doi: 10.1016/j.forsciint.2023.111876. Epub 2023 Nov 1.
The primary objective of postmortem forensic toxicology is to determine if toxicological substances detected in bodily material of victims have contributed to the death of the victim. Interpretation of postmortem drug concentrations is hindered by the fact that time and site dependent variations in postmortem drug concentrations occur, as a result of postmortem redistribution (PMR). An often-used marker for the occurrence of PMR, is the cardiac blood concentration/peripheral blood concentration ratio (C/P ratio) of a drug. In this study, we investigated the relationship between 13 variables and the C/P ratios of amphetamines and benzodiazepines.
Toxicological results of all postmortem cases that were positive for amphetamines (amphetamine, MDMA, MDA) and/or benzodiazepines (diazepam, desmethyldiazepam, temazepam, oxazepam, midazolam, α-hydroxymidazolam) investigated by the Netherlands Forensic Institute between January 1 2010 and July 31 2020 were reviewed. A total of 112 amphetamine positive cases (224 paired specimen) and 179 benzodiazepine positive cases (358 paired specimen) were selected. The C/P ratios were determined for all selected cases. Ratios were compared between subgroups by performing either a Mann-Whitney U test or a Kruskal-Wallis test followed by post-hoc Mann-Whitney U test.
After dividing cases in quartiles based on their amphetamine concentration in femoral blood, the amphetamine C/P ratio was significantly lower in cases with a high amphetamine concentration (quartile 4) compared to cases with a low amphetamine concentration (quartiles 1 and 2) with median C/P ratios of 1.6, 2.4 and 2.2, respectively (p-value<0.001 and p-value=0.001, respectively). The MDA C/P ratio was significantly higher in cases where trauma was the cause of death compared to cases where intoxication was the cause of death with median C/P ratios of 3.3 and 1.6, respectively (p-value<0.001). The MDA C/P ratio was also significantly lower in cases where resuscitation was attempted compared to cases where no resuscitation was attempted with median C/P ratios of 1.6 and 2.4, respectively (p-value=0.003). However, a significant dependency between the variables cause of death and attempted resuscitation was observed. No significant differences in benzodiazepine C/P ratios were observed between subgroups of any of the investigated variables. However, the low p-value of BMI suggests a potential difference in midazolam C/P ratio between BMI subgroups (p-value=0.027).
When interpreting postmortem toxicological results, it might prove useful to take the above-mentioned variables into account.
法医毒理学的主要目的是确定在受害者身体组织中检测到的毒物是否导致了受害者的死亡。由于死后药物再分布(PMR)的存在,导致尸体中药物浓度会随时间和地点发生变化,这给死后药物浓度的解读带来了困难。通常用于表示 PMR 发生的标志物是药物的心脏血液浓度/外周血液浓度比值(C/P 比值)。在这项研究中,我们调查了 13 个变量与苯丙胺和苯二氮䓬类药物的 C/P 比值之间的关系。
回顾了荷兰法医研究所 2010 年 1 月 1 日至 2020 年 7 月 31 日期间对所有苯丙胺(苯丙胺、MDMA、MDA)和/或苯二氮䓬类(地西泮、去甲西泮、替马西泮、奥沙西泮、咪达唑仑、α-羟基咪达唑仑)阳性的死后案例的毒理学结果。共选择了 112 例苯丙胺阳性病例(224 对标本)和 179 例苯二氮䓬阳性病例(358 对标本)。对所有选定的病例都确定了 C/P 比值。通过 Mann-Whitney U 检验或 Kruskal-Wallis 检验后进行事后 Mann-Whitney U 检验,比较亚组之间的比值。
根据股动脉中苯丙胺浓度将病例分为四等分后,高浓度苯丙胺(第 4 四分位数)组的苯丙胺 C/P 比值明显低于低浓度苯丙胺(第 1 和第 2 四分位数)组,中位数 C/P 比值分别为 1.6、2.4 和 2.2(p 值均<0.001 和 p 值=0.001)。与中毒为死因的病例相比,创伤为死因的病例中 MDA C/P 比值明显升高,中位数 C/P 比值分别为 3.3 和 1.6(p 值均<0.001)。与未进行复苏的病例相比,尝试复苏的病例中 MDA C/P 比值明显降低,中位数 C/P 比值分别为 1.6 和 2.4(p 值均=0.003)。然而,观察到变量死因和尝试复苏之间存在显著的依赖性。在任何调查变量的亚组中,苯二氮䓬类 C/P 比值均无显著差异。但是,BMI 的低 p 值表明中值唑仑 C/P 比值可能存在 BMI 亚组之间的差异(p 值=0.027)。
在解读死后毒理学结果时,考虑上述变量可能会有所帮助。